Application 203435
- Type
- ANDA
- Sponsor
- NOVAST LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LERIBANE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 0.005MG;1MG | No | No |
| 002 | LERIBANE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 0.0025MG;0.5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 75834-129 | Norethindrone Acetate and Ethinyl Estradiol | Norethindrone Acetate and Ethinyl Estradiol | Nivagen Pharmaceuticals, Inc. | ANDA | Current |
| 75834-130 | Norethindrone Acetate and Ethinyl Estradiol | Norethindrone Acetate and Ethinyl Estradiol | Nivagen Pharmaceuticals, Inc. | ANDA | Current |